Anika Therapeutics, Inc. (NASDAQ:ANIK) showed up in the 13F filings of 123 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 1,594,893 | -59,644 | -3.60% | $23,125,950.00 |
| Caligan Partners LP | 31 Mar, 2026 | 1,435,130 | 0 | 0.00% | $20,809,385.00 |
| Morgan Stanley | 31 Mar, 2026 | 872,066 | 99,836 | 12.93% | $12,644,959.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 606,544 | 0 | 0.00% | $8,789.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 605,777 | 605,777 | 0.00% | $8,783,767.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Mar, 2026 | 529,503 | -5,004 | -0.94% | $7,677,794.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 502,217 | -13,500 | -2.62% | $7,282,147.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 458,847 | -35,472 | -7.18% | $6,653,069.00 |
| CAPITAL MANAGEMENT CORP /VA | 31 Mar, 2026 | 447,721 | -52,744 | -10.54% | $6,491,947.00 |
| DEUTSCHE BANK AG\ | 31 Mar, 2026 | 353,174 | 271,884 | 334.46% | $5,121,023.00 |
| State Street Corp | 31 Mar, 2026 | 346,092 | 9,549 | 2.84% | $5,018,334.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 330,051 | 4,529 | 1.39% | $4,787,275.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 272,269 | 202,989 | 293.00% | $3,947,901.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Mar, 2026 | 265,627 | 70,042 | 35.81% | $3,851,592.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 236,120 | 2,312 | 0.99% | $3,423,740.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 229,796 | -68,183 | -22.88% | $3,332,042.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 217,878 | -111,974 | -33.95% | $3,159,232.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Mar, 2026 | 137,584 | 37,263 | 37.14% | $1,994,968.00 |
| UBS Group AG | 31 Mar, 2026 | 133,074 | 104,529 | 366.19% | $1,929,574.00 |
| Quantinno Capital Management LP | 31 Mar, 2026 | 125,826 | 24,277 | 23.91% | $1,824,477.00 |